Role of the Gut Microbiome in Anti-tumor Therapy Induced Diarrhea
NCT05873231 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2025-11-25
Summary
The role of the gut microbiome in the development of side effects of anti cancer treatment will be assessed in this longitudinal cohort study.
Conditions
Sponsors & Collaborators
-
Medical University of Graz
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-28
- Primary Completion
- 2030-12-31
- Completion
- 2032-12-31
Countries
- Austria
Study Locations
More Related Trials
-
FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach
NCT06071312 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool
NCT04067440 ·Status: COMPLETED
-
Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection
NCT02148601 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Influence of Diet on GI Health
NCT04783142 ·Status: COMPLETED ·Phase: NA
-
Relationship Between C. Difficile Toxins' Serum Level With C. Difficile Infection
NCT03586206 ·Status: UNKNOWN
-
Biogeography of the Oral Microbiome
NCT05672953 ·Status: COMPLETED
-
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection
NCT02686645 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy Adults
NCT05930197 ·Status: COMPLETED ·Phase: PHASE1
-
Interaction Between Non-typhoid Salmonella, Host Microbiota, and Immune System During Acute Infection and Remission
NCT03494101 ·Status: UNKNOWN
-
Evaluation of Gut Microbiota and Its Associated Resistome in FMT Donors and Recipients Due to Recurrent Clostridiodes Difficile Infection
NCT06533800 ·Status: NOT_YET_RECRUITING
-
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
NCT05622721 ·Status: ACTIVE_NOT_RECRUITING
-
Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection
NCT02237859 ·Status: UNKNOWN ·Phase: PHASE4
-
The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection
NCT04679324 ·Status: WITHDRAWN
-
Outcomes of Outpatients in an Gut Microbiota Clinic
NCT06845527 ·Status: RECRUITING
-
Study of the Interactions Between Dientamoba Fragilis and the Gut Microbiota
NCT02534272 ·Status: TERMINATED
-
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
NCT04668014 ·Status: COMPLETED
-
Intestinal Microbiota and Antimicrobial Resistance in Hong Kong Residents After Travel
NCT03794479 ·Status: COMPLETED
-
Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms
NCT06524791 ·Status: NOT_YET_RECRUITING
-
CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Diarrhoea in Adults
NCT06839599 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
The Role of the Gut Microbiota in the Systemic Immune Response During Human Endotoxemia
NCT02127749 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection
NCT03427229 ·Status: COMPLETED ·Phase: PHASE2
-
Descriptive Epidemiology of Clostridium Difficile Infection in Hospitalized Adult Patients in the Asia Pacific Region
NCT01560832 ·Status: COMPLETED
-
Studies of the Human Microbiome in Clinical Center Patients
NCT01933620 ·Status: ENROLLING_BY_INVITATION
-
Mucosal Versus Fecal Microbiota in FMT
NCT02133651 ·Status: COMPLETED